PHARMACOKINETICS OF N-4-HYDROXYPHENYL-RETINAMIDE AND THE EFFECT OF ITS ORAL-ADMINISTRATION ON PLASMA RETINOL CONCENTRATIONS IN CANCER-PATIENTS

被引:62
作者
PENG, YM
DALTON, WS
ALBERTS, DS
XU, MJ
LIM, H
MEYSKENS, FL
机构
[1] UNIV ARIZONA,COLL MED,DEPT INTERNAL MED,HEMATOL & ONCOL SECT,TUCSON,AZ 85724
[2] UNIV ARIZONA,COLL MED,DEPT PHARMACOL,TUCSON,AZ 85724
关键词
D O I
10.1002/ijc.2910430106
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:22 / 26
页数:5
相关论文
共 22 条
[11]  
MOON RC, 1985, RETINOIDS DIFFERENTI, P156
[12]  
SAFFIOTTI U, 1967, CANCER-AM CANCER SOC, V20, P857, DOI 10.1002/1097-0142(1967)20:5&lt
[13]  
857::AID-CNCR2820200545&gt
[14]  
3.0.CO
[15]  
2-3
[16]   CSTRIP, A FORTRAN-4 COMPUTER-PROGRAM FOR OBTAINING INITIAL POLYEXPONENTIAL PARAMETER ESTIMATES [J].
SEDMAN, AJ ;
WAGNER, JG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (07) :1006-1010
[17]  
SPORN MD, 1978, FED PROC, V38, P2528
[18]  
SWANSON BN, 1980, DRUG METAB DISPOS, V8, P168
[19]  
SWANSON BN, 1981, J PHARMACOL EXP THER, V219, P632
[20]  
TROWN PW, 1976, CANCER TREAT REP, V60, P1647